During the past decade, we have seen more remissions and even cures with the development of new, more effective, anti-cancer drugs and, recently, we have seen development of genetically engineered antibody and antigen treatments...Now, anti-inflammatory drugs, which have minimal or no side effects have an increasing a role to play in the successful treatment of cancer patients.
Keeping patients healthy, by reducing inflammation, during and after their treatments for their cancer, is a continuing challenge.